ALFA Finder| Revenue growth | +20.7% QoQ; +5.2% YoY |
|---|---|
| Margins | Gross margin 79.9% (+350 bps YoY); EBITDA margin 29.6% (-50 bps YoY) |
| Demand visibility | Repeat held ~35%; returns down ~60%; no order book |
| Management confidence | Upbeat: 'solid first half', 'more to sell' in H2 |
Growth
Revenue +5.2% YoY; PAT +19.8% YoY. EBITDA +3.4% YoY, margin down 50 bps; gross margin up 350 bps.
Outlook
No numeric guidance. Skincare launch by December 2026; PRO distribution expansion; international launch 'soon'; no capex plans disclosed.
Risks
Other income (₹72.2 lakh) flatters PBT; over 90% of sales from own website; skincare and PRO execution; receivables up 22% since March.
Investor Presentation filed with BSE, BSE: 544629. Summary written with AI assistance from the document.
Ravelcare Ltd: key numbers
- Share price
- ₹98.00
- Market cap
- ₹67.22 Cr
- Revenue (annual)
- ₹26.95 Cr
- Net profit (annual)
- ₹5.15 Cr
- P/E (TTM)
- 13.0×Sector 40.7×
- Promoter holding
- 72.94%
- FII holding
- 1.82%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ravelcare Ltd
All →Ravelcare Results Update
Ravelcare's H1 FY27 unaudited profit after tax nearly doubled to ₹3.84 crore on 20.7% revenue growth. A personalised skincare range is slated for launch by December 2026.
Ravelcare Other Announcement
Ravelcare reported no deviation in IPO fund use for the half year ended 30 September 2026. Rs.1,328.60 lakh of Rs.2,410.20 lakh proceeds were utilised.
Ravelcare H1 FY27 Results: Net Profit ₹3.8 Cr, Up 18.7% YoY
Ravelcare Limited's board approved unaudited standalone results for the half year ended September 2026. The results carry a limited review report from statutory auditors.
- Key figure
- Net profit ₹3.8 Cr · +18.7% YoY
Ravelcare Board Meeting Date
Ravelcare will meet on November 12, 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after the results declaration.
Ravelcare Other Announcement
Ravelcare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations. This is a routine compliance disclosure.
Ravelcare Annual General Meeting
Ravelcare Ltd submitted the proceedings of its 8th AGM held on September 23, 2026. Items covered adoption of audited FY26 financials and re-appointment of the MD, WTD, and a retiring director.